President Trump’s doctor downplayed an unsightly red rash on the commander-in-chief’s neck as the byproduct of a ...

Among patients with moderate to severe atopic dermatitis, APG777 produced significant reductions in disease severity at 16 weeks.

Lynk Pharmaceuticals has reported another phase 3 win in China for its next-gen JAK inhibitor, this time hitting skin clearance goals among patients with eczema. | Lynk Pharmaceuticals has reported ...

Turn Therapeutics (NASDAQ:TTRX) executives outlined the company’s focus on inflammatory skin disease and provided updates on its lead topical candidate, GX-03, during a presentation at an ...

Organon reports Phase 3 data showing VTAMA improved sleep in children as young as two with atopic dermatitis, reinforcing its dermatology push.

Among patients aged 2 to 17 years with moderate to severe atopic dermatitis, tapinarof cream 1% significantly improved sleep, ...

Dr Swanson tells families that almost all kids get poxvirus-caused bumps and while treatment isn’t mandatory, options include topical cantharidin, berdazimer gel, and intralesional candida injections.

Minimal disease activity in atopic dermatitis is sustainable at one year in early responders. Discover predictors and ...

NOW is Ovarian Cancer Awareness Month – and the symptoms of this disease are so frequently misdiagnosed as “just bloating” or irritable bowel syndrome (IBS). Unlike some cancers, with obvious ...

Brandi Jones has over two decades of experience as a nurse in an acute care setting. Her clinical background includes pediatrics, medical-surgical, and women's health. She also specializes in ...

While Holi is a festival of colours many avoid it fearing rashes and dark patches Our expert explains aesthetic treatments ...

Tralokinumab is effective for the treatment of AD through 72 weeks across body regions, including the head/neck, trunk, and limbs.